Orforglipron
ATTAIN-OA PAIN
Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 800
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Orforglipron (GZT1) | Osteoarthritis | n/r | 74 | n/r | n/r |
| Placebo (GZT1) | Osteoarthritis | n/r | 74 | n/r | n/r |
| Orforglipron (GZT2) | Osteoarthritis | n/r | 74 | n/r | n/r |
| Placebo (GZT2) | Osteoarthritis | n/r | 74 | n/r | n/r |